Fertilisers and Chemicals Travancore Valuation

Q: What is the Fair Price of FACT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

FACT (₹1012.8) is trading above our estimate of [[fair value]] (₹51.21)

Is FACT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of FACT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: FACT (₹1012.8) is trading above our estimate of fair value (₹51.21)

Significantly Below Fair Value: FACT is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FACT?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for FACT. This is calculated by dividing FACT's market cap by their current preferred multiple.
What is FACT's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	₹655.35b

FACT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	14.6x
Enterprise Value/EBITDA	415.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does FACT's PS Ratio compare to its peers?

The above table shows the PS ratio for FACT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	4.6x
523642 PI Industries	9x	14.8%	₹706.1b
COROMANDEL Coromandel International	2.4x	8.1%	₹509.5b
512070 UPL	1.1x	8.4%	₹454.0b
506285 Bayer CropScience	5.8x	11.3%	₹289.5b
FACT Fertilisers and Chemicals Travancore	14.8x	n/a	₹655.4b

Price-To-Sales vs Peers: FACT is expensive based on its Price-To-Sales Ratio (14.8x) compared to the peer average (4.6x).

Price to Earnings Ratio vs Industry

How does FACT's PE Ratio compare vs other companies in the IN Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	20.6%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: FACT is expensive based on its Price-To-Sales Ratio (14.8x) compared to the Indian Chemicals industry average (1.9x).

Price to Sales Ratio vs Fair Ratio

What is FACT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FACT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	14.8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate FACT's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.